Boehringer Ingelheim公司寻找一种有机小分子，能够安全使用，没有生物活性，或非常温和的生物活性，能够显示细胞的渗透性，并且在长期口服的情况下能够达到高血药浓度。
有机小分子常见于：药物化学，内科医师，配方科学（盖仑制剂），药剂学，药理学等领域。
有机小分子不常见于 ：动物医疗，农业科学，食物化学，营养学，化妆品，或其他等领域。
投标截止时期2016年6月26日,
投标网址：https://www.innocentive.com/ar/projectRoom/index?challenge=9933854
Seeking Safe Drug-like Small Organic Molecules for Human Use with Negligible Biological Effects
TAGS:
Chemistry, Life Sciences, Food/Agriculture, Royal Society of Chemistry, Ideation
AWARD: $20,000 USD | DEADLINE: 6/26/16 | ACTIVE SOLVERS: 106 | POSTED: 4/27/16
Boehringer Ingelheim (The Seeker) is interested in small organic molecules that are safe for human use, show no, or very mild, biological activity, display cell permeability, and achieve high concentrations (µM) in the plasma when chronically administered via the oral route.
This is an Ideation Challenge with a guaranteed award for at least one submitted solution.
Source: InnoCentive Challenge ID: 9933854
Sign Agreement For This Challenge
By electronically signing the agreement below, you are indicating your intention to view the details of this specific InnoCentive Challenge.
Viewing the Challenge Details does not obligate you to perform any work on this challenge. Print this Agreement for your records
InnoCentive Ideation Challenge-Specific Agreement
Please Read This Carefully! You and InnoCentive are agreeing to a Challenge-Specific Solver Agreement for this particular InnoCentive Ideation Challenge only. The Seeker for this InnoCentive Challenge has required that you accept these special terms, so please take the time to understand them.
If you click \\"I agree\\" and proceed to the Project Room for this InnoCentive Challenge, this Challenge-Specific Agreement (\\"CSA\\") will be a valid and binding agreement between you and InnoCentive and in addition to the existing Terms of Use for all purposes relating to this InnoCentive Challenge. Please print and keep a copy of this CSA. No provisions you may have
[更多]
